0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Embolic Gelatin Microspheres Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-30R16750
Home | Market Reports | Health| Medical Devices & Equipment
Global Embolic Gelatin Microspheres Market Research Report 2024
BUY CHAPTERS

Global Embolic Gelatin Microspheres Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30R16750
Report
November 2025
Pages:163
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Embolic Gelatin Microspheres Market

The global Embolic Gelatin Microspheres market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Embolic gelatin microspheres are small, biocompatible particles used in medical procedures such as embolization. Embolization is a minimally invasive technique used to block blood vessels, typically to treat conditions like tumors, aneurysms, or abnormal blood vessels. The procedure involves injecting embolic agents into blood vessels to obstruct or reduce blood flow to a specific area.
From a downstream perspective, Uterine Fibroid Embolization (UFE) accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Embolic Gelatin Microspheres leading manufacturers including Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, ABK Biomedical, BTG Medical, Cook Medical, Teleflex, Nexsphere, etc., dominate supply; the top five capture approximately % of global revenue, with Merit Medical Systems leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Embolic Gelatin Microspheres market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Embolic Gelatin Microspheres Market Report

Report Metric Details
Report Name Embolic Gelatin Microspheres Market
Segment by Type
  • Polyvinyl Alcohol (PVA) Microspheres
  • Trisacryl Gelatin Microspheres
  • Others
Segment by Application
  • Uterine Fibroid Embolization (UFE)
  • Liver Tumor Embolization
  • Arteriovenous Malformation (AVM) Embolization
  • Hemorrhage Control
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, ABK Biomedical, BTG Medical, Cook Medical, Teleflex, Nexsphere, Penumbra, Varian
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Embolic Gelatin Microspheres study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Embolic Gelatin Microspheres Market report?

Ans: The main players in the Embolic Gelatin Microspheres Market are Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, ABK Biomedical, BTG Medical, Cook Medical, Teleflex, Nexsphere, Penumbra, Varian

What are the Application segmentation covered in the Embolic Gelatin Microspheres Market report?

Ans: The Applications covered in the Embolic Gelatin Microspheres Market report are Uterine Fibroid Embolization (UFE), Liver Tumor Embolization, Arteriovenous Malformation (AVM) Embolization, Hemorrhage Control, Others

What are the Type segmentation covered in the Embolic Gelatin Microspheres Market report?

Ans: The Types covered in the Embolic Gelatin Microspheres Market report are Polyvinyl Alcohol (PVA) Microspheres, Trisacryl Gelatin Microspheres, Others

1 Study Coverage
1.1 Introduction to Embolic Gelatin Microspheres: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Embolic Gelatin Microspheres Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Polyvinyl Alcohol (PVA) Microspheres
1.2.3 Trisacryl Gelatin Microspheres
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Embolic Gelatin Microspheres Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Uterine Fibroid Embolization (UFE)
1.3.3 Liver Tumor Embolization
1.3.4 Arteriovenous Malformation (AVM) Embolization
1.3.5 Hemorrhage Control
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Embolic Gelatin Microspheres Revenue Estimates and Forecasts 2020-2031
2.2 Global Embolic Gelatin Microspheres Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Embolic Gelatin Microspheres Sales Estimates and Forecasts 2020-2031
2.4 Global Embolic Gelatin Microspheres Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Embolic Gelatin Microspheres Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Embolic Gelatin Microspheres Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Polyvinyl Alcohol (PVA) Microspheres Market Size by Manufacturers
3.5.2 Trisacryl Gelatin Microspheres Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Embolic Gelatin Microspheres Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Embolic Gelatin Microspheres Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Embolic Gelatin Microspheres Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Embolic Gelatin Microspheres Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Embolic Gelatin Microspheres Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Embolic Gelatin Microspheres Sales and Revenue by Type (2020-2031)
6.4 North America Embolic Gelatin Microspheres Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Embolic Gelatin Microspheres Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Embolic Gelatin Microspheres Sales and Revenue by Type (2020-2031)
7.4 Europe Embolic Gelatin Microspheres Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Embolic Gelatin Microspheres Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Embolic Gelatin Microspheres Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Embolic Gelatin Microspheres Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Embolic Gelatin Microspheres Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Embolic Gelatin Microspheres Sales and Revenue by Type (2020-2031)
9.4 Central and South America Embolic Gelatin Microspheres Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Embolic Gelatin Microspheres Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Embolic Gelatin Microspheres Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Embolic Gelatin Microspheres Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Embolic Gelatin Microspheres Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Merit Medical Systems
11.1.1 Merit Medical Systems Corporation Information
11.1.2 Merit Medical Systems Business Overview
11.1.3 Merit Medical Systems Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.1.4 Merit Medical Systems Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Merit Medical Systems Embolic Gelatin Microspheres Sales by Product in 2024
11.1.6 Merit Medical Systems Embolic Gelatin Microspheres Sales by Application in 2024
11.1.7 Merit Medical Systems Embolic Gelatin Microspheres Sales by Geographic Area in 2024
11.1.8 Merit Medical Systems Embolic Gelatin Microspheres SWOT Analysis
11.1.9 Merit Medical Systems Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.2.4 Medtronic Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Embolic Gelatin Microspheres Sales by Product in 2024
11.2.6 Medtronic Embolic Gelatin Microspheres Sales by Application in 2024
11.2.7 Medtronic Embolic Gelatin Microspheres Sales by Geographic Area in 2024
11.2.8 Medtronic Embolic Gelatin Microspheres SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Corporation Information
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.3.4 Boston Scientific Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Boston Scientific Embolic Gelatin Microspheres Sales by Product in 2024
11.3.6 Boston Scientific Embolic Gelatin Microspheres Sales by Application in 2024
11.3.7 Boston Scientific Embolic Gelatin Microspheres Sales by Geographic Area in 2024
11.3.8 Boston Scientific Embolic Gelatin Microspheres SWOT Analysis
11.3.9 Boston Scientific Recent Developments
11.4 Terumo
11.4.1 Terumo Corporation Information
11.4.2 Terumo Business Overview
11.4.3 Terumo Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.4.4 Terumo Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Terumo Embolic Gelatin Microspheres Sales by Product in 2024
11.4.6 Terumo Embolic Gelatin Microspheres Sales by Application in 2024
11.4.7 Terumo Embolic Gelatin Microspheres Sales by Geographic Area in 2024
11.4.8 Terumo Embolic Gelatin Microspheres SWOT Analysis
11.4.9 Terumo Recent Developments
11.5 Sirtex Medical
11.5.1 Sirtex Medical Corporation Information
11.5.2 Sirtex Medical Business Overview
11.5.3 Sirtex Medical Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.5.4 Sirtex Medical Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sirtex Medical Embolic Gelatin Microspheres Sales by Product in 2024
11.5.6 Sirtex Medical Embolic Gelatin Microspheres Sales by Application in 2024
11.5.7 Sirtex Medical Embolic Gelatin Microspheres Sales by Geographic Area in 2024
11.5.8 Sirtex Medical Embolic Gelatin Microspheres SWOT Analysis
11.5.9 Sirtex Medical Recent Developments
11.6 ABK Biomedical
11.6.1 ABK Biomedical Corporation Information
11.6.2 ABK Biomedical Business Overview
11.6.3 ABK Biomedical Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.6.4 ABK Biomedical Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ABK Biomedical Recent Developments
11.7 BTG Medical
11.7.1 BTG Medical Corporation Information
11.7.2 BTG Medical Business Overview
11.7.3 BTG Medical Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.7.4 BTG Medical Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 BTG Medical Recent Developments
11.8 Cook Medical
11.8.1 Cook Medical Corporation Information
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.8.4 Cook Medical Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Cook Medical Recent Developments
11.9 Teleflex
11.9.1 Teleflex Corporation Information
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.9.4 Teleflex Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Teleflex Recent Developments
11.10 Nexsphere
11.10.1 Nexsphere Corporation Information
11.10.2 Nexsphere Business Overview
11.10.3 Nexsphere Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.10.4 Nexsphere Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Nexsphere Recent Developments
11.11 Penumbra
11.11.1 Penumbra Corporation Information
11.11.2 Penumbra Business Overview
11.11.3 Penumbra Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.11.4 Penumbra Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Penumbra Recent Developments
11.12 Varian
11.12.1 Varian Corporation Information
11.12.2 Varian Business Overview
11.12.3 Varian Embolic Gelatin Microspheres Product Models, Descriptions and Specifications
11.12.4 Varian Embolic Gelatin Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Varian Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Embolic Gelatin Microspheres Industry Chain
12.2 Embolic Gelatin Microspheres Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Embolic Gelatin Microspheres Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Embolic Gelatin Microspheres Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Embolic Gelatin Microspheres Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Embolic Gelatin Microspheres Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Embolic Gelatin Microspheres Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Embolic Gelatin Microspheres Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Embolic Gelatin Microspheres Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Embolic Gelatin Microspheres Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Embolic Gelatin Microspheres Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
 Table 7. Global Embolic Gelatin Microspheres Sales by Region (2020-2025) & (kg)
 Table 8. Global Embolic Gelatin Microspheres Sales by Region (2026-2031) & (kg)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Embolic Gelatin Microspheres Sales by Manufacturers (2020-2025) & (kg)
 Table 11. Global Embolic Gelatin Microspheres Sales Share by Manufacturers (2020-2025)
 Table 12. Global Embolic Gelatin Microspheres Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Embolic Gelatin Microspheres Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Embolic Gelatin Microspheres by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolic Gelatin Microspheres as of 2024)
 Table 16. Global Embolic Gelatin Microspheres Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Embolic Gelatin Microspheres Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
 Table 18. Key Manufacturers Embolic Gelatin Microspheres Manufacturing Base and Headquarters
 Table 19. Global Embolic Gelatin Microspheres Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Embolic Gelatin Microspheres Sales by Type (2020-2025) & (kg)
 Table 23. Global Embolic Gelatin Microspheres Sales by Type (2026-2031) & (kg)
 Table 24. Global Embolic Gelatin Microspheres Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Embolic Gelatin Microspheres Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Embolic Gelatin Microspheres ASP by Type (2020-2031) & (US$/g)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Embolic Gelatin Microspheres Sales by Application (2020-2025) & (kg)
 Table 29. Global Embolic Gelatin Microspheres Sales by Application (2026-2031) & (kg)
 Table 30. Embolic Gelatin Microspheres High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Embolic Gelatin Microspheres Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Embolic Gelatin Microspheres Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Embolic Gelatin Microspheres ASP by Application (2020-2031) & (US$/g)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Embolic Gelatin Microspheres Growth Accelerators and Market Barriers
 Table 37. North America Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Embolic Gelatin Microspheres Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Embolic Gelatin Microspheres Growth Accelerators and Market Barriers
 Table 40. Europe Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Embolic Gelatin Microspheres Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Embolic Gelatin Microspheres Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Embolic Gelatin Microspheres Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Embolic Gelatin Microspheres Investment Opportunities and Key Challenges
 Table 47. Central and South America Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Embolic Gelatin Microspheres Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Embolic Gelatin Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Merit Medical Systems Corporation Information
 Table 51. Merit Medical Systems Description and Major Businesses
 Table 52. Merit Medical Systems Product Models, Descriptions and Specifications
 Table 53. Merit Medical Systems Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 54. Merit Medical Systems Sales Value Proportion by Product in 2024
 Table 55. Merit Medical Systems Sales Value Proportion by Application in 2024
 Table 56. Merit Medical Systems Sales Value Proportion by Geographic Area in 2024
 Table 57. Merit Medical Systems Embolic Gelatin Microspheres SWOT Analysis
 Table 58. Merit Medical Systems Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Embolic Gelatin Microspheres SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. Boston Scientific Corporation Information
 Table 69. Boston Scientific Description and Major Businesses
 Table 70. Boston Scientific Product Models, Descriptions and Specifications
 Table 71. Boston Scientific Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 72. Boston Scientific Sales Value Proportion by Product in 2024
 Table 73. Boston Scientific Sales Value Proportion by Application in 2024
 Table 74. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 75. Boston Scientific Embolic Gelatin Microspheres SWOT Analysis
 Table 76. Boston Scientific Recent Developments
 Table 77. Terumo Corporation Information
 Table 78. Terumo Description and Major Businesses
 Table 79. Terumo Product Models, Descriptions and Specifications
 Table 80. Terumo Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 81. Terumo Sales Value Proportion by Product in 2024
 Table 82. Terumo Sales Value Proportion by Application in 2024
 Table 83. Terumo Sales Value Proportion by Geographic Area in 2024
 Table 84. Terumo Embolic Gelatin Microspheres SWOT Analysis
 Table 85. Terumo Recent Developments
 Table 86. Sirtex Medical Corporation Information
 Table 87. Sirtex Medical Description and Major Businesses
 Table 88. Sirtex Medical Product Models, Descriptions and Specifications
 Table 89. Sirtex Medical Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 90. Sirtex Medical Sales Value Proportion by Product in 2024
 Table 91. Sirtex Medical Sales Value Proportion by Application in 2024
 Table 92. Sirtex Medical Sales Value Proportion by Geographic Area in 2024
 Table 93. Sirtex Medical Embolic Gelatin Microspheres SWOT Analysis
 Table 94. Sirtex Medical Recent Developments
 Table 95. ABK Biomedical Corporation Information
 Table 96. ABK Biomedical Description and Major Businesses
 Table 97. ABK Biomedical Product Models, Descriptions and Specifications
 Table 98. ABK Biomedical Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 99. ABK Biomedical Recent Developments
 Table 100. BTG Medical Corporation Information
 Table 101. BTG Medical Description and Major Businesses
 Table 102. BTG Medical Product Models, Descriptions and Specifications
 Table 103. BTG Medical Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 104. BTG Medical Recent Developments
 Table 105. Cook Medical Corporation Information
 Table 106. Cook Medical Description and Major Businesses
 Table 107. Cook Medical Product Models, Descriptions and Specifications
 Table 108. Cook Medical Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 109. Cook Medical Recent Developments
 Table 110. Teleflex Corporation Information
 Table 111. Teleflex Description and Major Businesses
 Table 112. Teleflex Product Models, Descriptions and Specifications
 Table 113. Teleflex Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 114. Teleflex Recent Developments
 Table 115. Nexsphere Corporation Information
 Table 116. Nexsphere Description and Major Businesses
 Table 117. Nexsphere Product Models, Descriptions and Specifications
 Table 118. Nexsphere Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 119. Nexsphere Recent Developments
 Table 120. Penumbra Corporation Information
 Table 121. Penumbra Description and Major Businesses
 Table 122. Penumbra Product Models, Descriptions and Specifications
 Table 123. Penumbra Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 124. Penumbra Recent Developments
 Table 125. Varian Corporation Information
 Table 126. Varian Description and Major Businesses
 Table 127. Varian Product Models, Descriptions and Specifications
 Table 128. Varian Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 129. Varian Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Embolic Gelatin Microspheres Product Picture
 Figure 2. Global Embolic Gelatin Microspheres Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Polyvinyl Alcohol (PVA) Microspheres Product Picture
 Figure 4. Trisacryl Gelatin Microspheres Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Embolic Gelatin Microspheres Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Uterine Fibroid Embolization (UFE)
 Figure 8. Liver Tumor Embolization
 Figure 9. Arteriovenous Malformation (AVM) Embolization
 Figure 10. Hemorrhage Control
 Figure 11. Others
 Figure 12. Embolic Gelatin Microspheres Report Years Considered
 Figure 13. Global Embolic Gelatin Microspheres Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Embolic Gelatin Microspheres Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Embolic Gelatin Microspheres Revenue Market Share by Region (2020-2031)
 Figure 17. Global Embolic Gelatin Microspheres Sales (2020-2031) & (kg)
 Figure 18. Global Embolic Gelatin Microspheres Sales (CAGR) by Region (2020-2031) (kg)
 Figure 19. Global Embolic Gelatin Microspheres Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Embolic Gelatin Microspheres Sales Volume Market Share in 2024
 Figure 21. Global Embolic Gelatin Microspheres Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Polyvinyl Alcohol (PVA) Microspheres Revenue Market Share by Manufacturer in 2024
 Figure 24. Trisacryl Gelatin Microspheres Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Embolic Gelatin Microspheres Sales Market Share by Type (2020-2031)
 Figure 27. Global Embolic Gelatin Microspheres Revenue Market Share by Type (2020-2031)
 Figure 28. Global Embolic Gelatin Microspheres Sales Market Share by Application (2020-2031)
 Figure 29. Global Embolic Gelatin Microspheres Revenue Market Share by Application (2020-2031)
 Figure 30. North America Embolic Gelatin Microspheres Sales YoY (2020-2031) & (kg)
 Figure 31. North America Embolic Gelatin Microspheres Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Embolic Gelatin Microspheres Sales Revenue (US$ Million) in 2024
 Figure 33. North America Embolic Gelatin Microspheres Sales Volume (kg) by Type (2020- 2031)
 Figure 34. North America Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Embolic Gelatin Microspheres Sales Volume (kg) by Application (2020-2031)
 Figure 36. North America Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Embolic Gelatin Microspheres Sales YoY (2020-2031) & (kg)
 Figure 41. Europe Embolic Gelatin Microspheres Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Embolic Gelatin Microspheres Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Embolic Gelatin Microspheres Sales Volume (kg) by Type (2020-2031)
 Figure 44. Europe Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Embolic Gelatin Microspheres Sales Volume (kg) by Application (2020-2031)
 Figure 46. Europe Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 48. France Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Embolic Gelatin Microspheres Sales YoY (2020-2031) & (kg)
 Figure 53. Asia-Pacific Embolic Gelatin Microspheres Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Embolic Gelatin Microspheres Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Embolic Gelatin Microspheres Sales Volume (kg) by Type (2020- 2031)
 Figure 56. Asia-Pacific Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Embolic Gelatin Microspheres Sales Volume (kg) by Application (2020-2031)
 Figure 58. Asia-Pacific Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 63. India Embolic Gelatin Microspheres Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Embolic Gelatin Microspheres Sales YoY (2020-2031) & (kg)
 Figure 65. Central and South America Embolic Gelatin Microspheres Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Embolic Gelatin Microspheres Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Embolic Gelatin Microspheres Sales Volume (kg) by Type (2021-2031)
 Figure 68. Central and South America Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Embolic Gelatin Microspheres Sales Volume (kg) by Application (2020-2031)
 Figure 70. Central and South America Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Embolic Gelatin Microspheres Sales YoY (2020-2031) & (kg)
 Figure 74. Middle East and Africa Embolic Gelatin Microspheres Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Embolic Gelatin Microspheres Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Embolic Gelatin Microspheres Sales Volume (kg) by Type (2021-2031)
 Figure 77. South America Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Embolic Gelatin Microspheres Sales Volume (kg) by Application (2020-2031)
 Figure 79. Middle East and Africa Embolic Gelatin Microspheres Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Embolic Gelatin Microspheres Revenue (2020-2025) & (US$ Million)
 Figure 84. Embolic Gelatin Microspheres Industry Chain Mapping
 Figure 85. Regional Embolic Gelatin Microspheres Manufacturing Base Distribution (%)
 Figure 86. Global Embolic Gelatin Microspheres Production Market Share by Region (2020-2031)
 Figure 87. Embolic Gelatin Microspheres Production Process
 Figure 88. Regional Embolic Gelatin Microspheres Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart